President & Chief Revenue Officer
Greg is EVERSANA’s President & Chief Revenue Officer. He is responsible for accelerating the company’s growth and ensuring the success of all client commercialization efforts. With more than 25 years of executive leadership, Greg understands all facets of the pharmaceutical industry, spanning clinical operations to commercial success. Greg’s previous roles include Chief Enterprise Business Officer and Executive Vice President and General Manager at a global bio-pharmaceutical solutions organization, where he successfully managed business units and teams of several thousand employees. Skalicky holds a Bachelor of Science in Biology from Temple University and a Master of Business Administration from Villanova University. He is an active member across several industry panels and consortiums.